NR1I3 and tuberculosis: In the current study on TB/HIV co-infected patients on concomitant first-line anti-TB and EFV-bases ART in Ethiopia, the association of specific NR1I3 and NR1I2 gene polymorphisms on EFV pharmacokinetics were observed.